You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1026 to 1050 of about 5901
Next 25
10/26/2019
NYU Langone Health launches new molecular assay to identify patients with brain tumors
10/24/2019
GBM patient and Caregiver Survey
10/22/2019
Donate or request expensive medicines!
10/10/2019
Oncology Pioneer xCures Names Experts to Advisory Boards
New Trial of Focused Ultrasound in Glioblastoma: Opening the Blood-Brain Barrier for Chemotherapy
First-line treatment of ONC 201 in newly diagnosed DIPG pediatric patients is now open.
10/09/2019
Any Amazon users?
09/30/2019
Optune Open House
09/27/2019
Barriers to accrual and enrollment in brain tumor trials
09/25/2019
Medicenna Presents Promising Update from its MDNA55 Clinical Trial in Recurrent Glioblastoma at the Targeting Innate Immunity Congress
09/14/2019
DeAngelis named MSK physician-in-chief, chief medical officer
09/13/2019
Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
09/11/2019
Frankly Speaking About Brain Tumors
Publication Reports Clinical Efficacy of ONC201 in Expanded Access H3 K27M-mutant Glioma Patients
09/09/2019
Bristol-Myers Squibb`s Opdivo fails 3rd straight test in tough-to-treat brain cancer
Novocure Announces 27 Presentations at the American Society for Radiation Oncology 2019 Annual Meeting
08/30/2019
Musella Foundation awards a pediatric brain tumor research grant!
08/15/2019
DelMar Pharmaceuticals Reports Updated Results on Twenty Patients from the Phase 2 Clinical Trial of VAL-083 as First-Line Treatment in Newly-Diagnosed MGMT-Unmethylated Glioblastoma MultiForme (GBM)
Attend an Optune Open House
08/03/2019
Validation of an effective implantable pump-infusion system for chronic convection-enhanced delivery of intracerebral topotecan in a large animal model.
Young adults diagnosed with high grade gliomas: Patterns of care, outcomes, and impact on employment.
07/29/2019
Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.
Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study.
Valerie Harper to stay out of hospice care, husband says
07/26/2019
Musella Foundation Brain Tumor Copay Program has reopened!